Related Experiment Video
Updated: Apr 3, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
Published on: May 27, 2016
SERBP1 Is a Component of the Liver Receptor Homologue-1 Transcriptional Complex
Yelenis Mari1, Graham M West1, Catherina Scharager-Tapia1
1Department of Molecular Therapeutics, ‡Mass Spectrometry & Proteomics Core, and §Informatics Core, The Scripps Research Institute , Jupiter, Florida 33458, United States.
Abstract:
Liver receptor homologue-1 (LRH1) is an orphan nuclear receptor that has been shown to play a role in the transcriptional regulation of pathways involved in cancer. Elucidating the components of the LRH1 transcriptional complex to better understand endogenous regulation of the receptor as well as its role in cancer remains a high priority. A sub-cellular enrichment strategy coupled with proteomic approaches was employed to identify putative LRH1 co-regulators. Nuclear fractionation protocol was essential for detection of LRH1 peptides by mass spectrometry (MS), with most peptides being observed in the insoluble fraction (receptor bound to DNA). SERBP1 and ILF3 were identified as LRH1 interacting partners by both Western blot and MS/MS analysis. Receptor knockdown by siRNA showed an increase in SERBP1 expression, while ILF3 expression was unchanged. In contrast, receptor overexpression decreased only SERBP1 mRNA levels. Consistent with these data, in a promoter:reporter assay, binding of LRH1 to the promoter region of SERBP1 resulted in a decrease in the expression level of the reporter gene, subsequently inhibiting transcription. Given the receptor's role in cancer progression, the study here elucidates additional transcriptional machinery involved in LRH1 signaling and potentially provides new targets for therapeutics development.
Insights
Liver receptor homologue-1 (LRH1) regulates gene transcription in cancer. Researchers identified SERBP1 and ILF3 as LRH1 partners, with LRH1 inhibiting SERBP1 expression, offering potential therapeutic targets.
Area of Science:
- Molecular biology
- Cancer research
- Nuclear receptor signaling
Background:
- Liver receptor homologue-1 (LRH1) is an orphan nuclear receptor implicated in cancer-related pathways.
- Understanding LRH1's transcriptional complex is crucial for elucidating its role in cancer and endogenous regulation.
Purpose of the Study:
- To identify co-regulators of LRH1 using proteomic approaches.
- To investigate the interaction between LRH1, SERBP1, and ILF3.
- To explore the functional consequences of LRH1 binding on SERBP1 transcription.
Main Methods:
- Sub-cellular enrichment and nuclear fractionation followed by mass spectrometry (MS).
- Western blot and MS/MS analysis to identify interacting partners.
- siRNA-mediated knockdown and overexpression studies.
- Promoter:reporter assays to assess transcriptional regulation.
Main Results:
- SERBP1 and ILF3 were identified as LRH1 interacting partners.
- LRH1 knockdown increased SERBP1 expression; LRH1 overexpression decreased SERBP1 mRNA.
- LRH1 binding to the SERBP1 promoter inhibited reporter gene expression, suppressing transcription.
Conclusions:
- The study identifies SERBP1 and ILF3 as components of the LRH1 transcriptional complex.
- LRH1 directly represses SERBP1 transcription.
- These findings provide insights into LRH1 signaling in cancer and suggest potential therapeutic targets.
Related Concept Videos
Regulation of Nuclear Protein Sorting
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Directing Proteins to the Rough Endoplasmic Reticulum
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors

